Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Nirogacestat demonstrates clinically significant improvement in PFS versus placebo for progressing desmoid tumours

Dr Bernd Kasper - Universitätsmedizin Mannheim, Mannheim, Germany
Nirogacestat demonstrates clinically significant improvement in PFS versus placebo for progressing desmoid tumours ( Dr Bernd Kasper - Universitätsmedizin Mannheim, Mannheim, Germany )
10 Sep 2022

Treatment with tumour-infiltrating lymphocytes versus ipilimumab significantly improved PFS for advanced melanoma

Dr John B Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands
Treatment with tumour-infiltrating lymphocytes versus ipilimumab significantly improved PFS for advanced melanoma ( Dr John B Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands )
10 Sep 2022

Cervical cancer programme in Kenya: lessons to guide elimination as a public health problem

Dr Valerian Mwenda - Ministry of Health, Nairobi, Kenya
Cervical cancer programme in Kenya: lessons to guide elimination as a public health problem ( Dr Valerian Mwenda - Ministry of Health, Nairobi, Kenya )
25 Aug 2022

An overview of treatment advances in gastric cancer

Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA
An overview of treatment advances in gastric cancer ( Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA )
18 Aug 2022

Optimum treatment strategy algorithm for mCRC

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
Optimum treatment strategy algorithm for mCRC ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
15 Aug 2022

Bladder cancer: Current state and future directions in treatment

Prof Jorge Garcia - GU Medical Oncology Program, UH Seidman Cancer Center, Case Western Reserve University, Cleveland, USA
Bladder cancer: Current state and future directions in treatment ( Prof Jorge Garcia - GU Medical Oncology Program, UH Seidman Cancer Center, Case Western Reserve University, Cleveland, USA )
15 Aug 2022

Optimum treatment algorithm in management of advanced prostate cancer

Prof Jorge Garcia - GU Medical Oncology Program, UH Seidman Cancer Center, Case Western Reserve University, Cleveland, USA
Optimum treatment algorithm in management of advanced prostate cancer ( Prof Jorge Garcia - GU Medical Oncology Program, UH Seidman Cancer Center, Case Western Reserve University, Cleveland, USA )
15 Aug 2022

Working to improve global cancer care access in low middle-income countries

Dr Julie Gralow, Prof Eduardo Cazap
Working to improve global cancer care access in low middle-income countries ( Dr Julie Gralow, Prof Eduardo Cazap )
25 Jul 2022

Update on the latest in PARP inhibitors for prostate cancer

Prof Axel Merseburger and Prof Bertrand Tombal
Update on the latest in PARP inhibitors for prostate cancer ( Prof Axel Merseburger and Prof Bertrand Tombal )
11 Jul 2022

ASCO Direct Highlights 2022: prostate cancer highlights

Dr Chandler Park - Baptist Health Hardin, Elizabethtown, USA
ASCO Direct Highlights 2022: prostate cancer highlights ( Dr Chandler Park - Baptist Health Hardin, Elizabethtown, USA )
9 Jul 2022

ASCO Direct Highlights 2022: lung cancer highlights

Dr Tom Stinchcombe - Duke Cancer Center, Durham, USA
ASCO Direct Highlights 2022: lung cancer highlights ( Dr Tom Stinchcombe - Duke Cancer Center, Durham, USA )
9 Jul 2022

Locally and advanced immunotherapy developments and new agents in lung cancer

Dr George Simon - Moffitt Advent Health Clinical Research Unit, Tampa, USA
Locally and advanced immunotherapy developments and new agents in lung cancer ( Dr George Simon - Moffitt Advent Health Clinical Research Unit, Tampa, USA )
9 Jul 2022